50
Participants
Start Date
December 31, 2009
Primary Completion Date
August 31, 2013
Study Completion Date
October 31, 2014
IMGN901
dose escalation study. dosing on days 1, 8 and 15 every 28 days
Weill Medical College, New York
Roswell Park Cancer Institute, Buffalo
Fox Chase Cancer Center, Philadelphia
Duke University Medical Center, Durham
Florida Cancer Specialists, Sarasota
Sarah Cannon Research Institute, Nashville
CTRC at University of Texas Health Science Center, San Antonio
University of Southern California, Los Angeles
Comprehensive Cancer Center of the Desert, Palm Springs
Lead Sponsor
ImmunoGen, Inc.
INDUSTRY